There were 1,845 press releases posted in the last 24 hours and 429,645 in the last 365 days.

Enteric Soft Gel Capsules Market Report Up to 2031: Visiongain Research Inc

Visiongain has published a new report on Enteric Soft Gel Capsules Market Report 2021-2031: Forecasts By Product Type (Gelatin Enteric Soft Gel Capsules, and Non-Gelatin Enteric Soft Gel Capsules), By Application (Pharmaceuticals, and Medical and Health Supplements), By Patient Demographics (Geriatric, Adult, and Pediatric), By End User (Hospitals, Homecare, Specialty Clinics, and Others), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies) PLUS Profiles of Leading Manufacturing Companies and Regional and Leading National Market Analysis. PLUS COVID-19 Recovery Scenarios.

Download Exclusive Sample of Report @

COVID-19 Impact on Enteric Soft Gel Capsules Market

COVID-19 impact through different recovery models such as V-shaped, U-shaped, W-shaped, and L-shaped; has been taken into consideration while estimating and forecasting the Enteric Soft Gel Capsules market. Different recovery scenarios are also included in the report for all the segments and regions/nation. The recovery scenarios based on which market has been forecasted and analysed herein the report are mentioned below:

Market Drivers
Growing Demand for Omega-3 Supplements around the World

Demand for omega-3 supplements is increasing due to increasing awareness regarding the importance of administration of preventive medicines and soft gel-based health supplements in developing and developed countries. With increasing demand of omega-3 supplements by hospitals, homecare, specialty clinics, and among others it is expected that, many of the manufacturers will launch their product portfolios in companion enteric soft gel capsules in the order to increase their revenue generation due to this reason the factor is working as a driver for the enteric soft gel capsules market.

Increasing Geriatric Population around the World

People are at a high risk of cognitive decline in old age due to reduced immune system and bone health, muscle performance. Elder people who are at high risk require to take enteric soft gel capsules (dietary supplementation) which have substantial benefits in reduction of cognitive decline risk in older people by maintaining preventing the loss of muscle mass and bone health and function associated with physiological ageing, immune function. Over the last few years, the number of geriatric populations is increasing very fast around the world. The region is facing rapid increase in the geriatric population. For instance: According to the United Nations, Department of Economic and Social Affairs, Population division geriatric population (persons aged 65 or over) was 702.9 million in 2019. Continuous increase in the number of the geriatric population around the world is also increasing demand for enteric soft gel capsules around the world.

Market Opportunities

Growing Awareness Regarding Consumption of Preventive Medicines

Awareness programs for consumption of preventive medicines from the governments, regulatory authorities, national & international organizations around the world is increasing very rapidly as compared to the last few years. Preventive care and medication always remain the matter of concern and research as it's been related to human life and survivors. Awareness programs are focusing to increase the awareness related to preventive care and medication to reduce mortality rate related to undiagnosed or untreated patients and to strengthen people’s immune systems. These awareness programs are expected to increase the demand of the enteric soft gel capsules in the forecasted periods.

Get Detailed TOC @

Competitive Landscape

Top companies (BASF SE, Catalent, Inc., Colorcon, Inc., and Fuji Capsules Co., Ltd.) constitute more than XX% share of the global Enteric Soft Gel Capsules market. Other companies profiled in the report include: Procaps, NOW Foods Inc., Thermo Fisher Scientific, Inc. (Patheon), Sirio Pharma Co., LTD, Super Spectrim, Osmotica Pharmaceuticals plc. (Trigen Laboratories, Inc.)) among others Some of the key developments are listed below:

  • In 2020, BIOSALMA has launched Omega-3 Pure and Natural product, which is fully certified to both MSC and ASC standards. The product is World’s First MSC and ASC Certified Omega-3 Supplements. The launch will help the company widen revenue generation from a market focused product portfolio.

Find quantitative and qualitative analyses with independent predictions. Receive information that only our report contains, staying informed with this invaluable business intelligence.

To access the data contained in this document please email

Information found nowhere else
With our newly report title, you are less likely to fall behind in knowledge or miss out on opportunities. See how our work could benefit your research, analyses, and decisions. Visiongain's study is for everybody needing commercial analyses for the Enteric soft gel capsules market and leading companies. You will find data, trends and predictions.

Find more Visiongain research reports on Pharma Drug Developments click on the following links:

Do you have any custom requirements we can help you with? Any need for a specific country, geo region, market segment or specific company information? Contact us today, we can discuss your needs and see how we can help:

About Visiongain

Visiongain is one of the fastest growing and most innovative, independent, market intelligence around, the company publishes hundreds of market research reports which it adds to its extensive portfolio each year. These reports offer in-depth analysis across 18 industries worldwide. The reports cover a 10-year forecast, are hundreds of pages long, with in depth market analysis and valuable competitive intelligence data. Visiongain works across a range of vertical markets, which currently can influence one another, these markets include automotive, aviation, chemicals, cyber, defense, energy, food & drink, materials, packaging, pharmaceutical and utilities sectors. Our customized and syndicated market research reports mean that you can have a bespoke piece of market intelligence customized to your very own business needs.


Catherine Walker
PR at Visiongain Inc.
Tel: + 44 0207 336 6100
USA Tel: + 1 718 682 4567
EU Tel: + 353 1 695 0006
Toll Free: 00-1-646-396-5129
Follow Us: LinkedIn | Twitter


SOURCE Visiongain Limited.

Primary Logo